Nomura Micro Science (6254) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
14 May, 2026Executive summary
Net sales for FY ended March 31, 2026, declined 41.6% YoY to ¥56,245 million, with operating profit down 56.6% to ¥6,667 million and profit attributable to owners of parent down 62.6% to ¥3,818 million.
Orders received dropped 49.5% YoY due to a reactionary decline after large-scale water treatment equipment orders in the prior year.
The semiconductor industry remained robust, but delays in project commencements and completion of prior large projects impacted results.
Financial highlights
Gross profit for FY2026 was ¥12,707 million, down from ¥21,110 million in FY2025.
Comprehensive income fell 50.8% YoY to ¥4,863 million.
Cash and cash equivalents at year-end decreased to ¥9,933 million from ¥16,539 million.
Equity to assets ratio improved to 35.6% from 31.2% YoY.
Outlook and guidance
FY2027 forecasts: net sales ¥97,000 million (+72.5% YoY), operating profit ¥16,000 million (+140.0%), profit attributable to owners of parent ¥11,100 million (+190.7%).
Orders received expected to surge 245.5% YoY to ¥164,780 million, driven by strong semiconductor sector demand.
Annual dividend forecast for FY2027 is ¥85 per share.
Latest events from Nomura Micro Science
- Strong sales and profit growth fueled by semiconductor demand; outlook remains positive.6254
Q3 202613 Feb 2026 - Strong sales and profit growth fueled by semiconductor demand and water treatment projects.6254
Q2 202614 Nov 2025 - Net sales and profits fell sharply year-over-year, but full-year guidance remains unchanged.6254
Q1 20253 Oct 2025 - Sharp year-over-year declines in sales and profit, but full-year guidance remains unchanged.6254
Q2 20253 Oct 2025 - FY25 saw record sales and profit, but FY26 forecasts a sharp decline due to project cycles.6254
Q4 20253 Oct 2025 - Sharp year-over-year declines, but strong FY2025 recovery forecast amid robust semiconductor demand.6254
Q3 20253 Oct 2025 - Revenue and profit soared on robust US and Japan demand; full-year outlook maintained.6254
Q1 20263 Oct 2025